Credit Agricole’s Moderna MRNA Stock Holding History

Credit Agricole’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-21,000	Closed	-$1.4M	–	1315
2024 Q3	$1.4M	Buy	21,000 +13,656	+186%	+$1.25M	0.01%	702
2024 Q2	$872K	Sell	7,344 -292,656	-98%	-$37M	﹤0.01%	753
2024 Q1	$30.6M	Sell	300,000 -300,000	-50%	-$30.2M	0.33%	56
2023 Q4	$59.7M	Buy	600,000 +50,000	+9%	+$4.21M	0.68%	27
2023 Q3	$56.8M	Buy	550,000 +290,000	+112%	+$32.3M	0.92%	17
2023 Q2	$31.6M	Buy	260,000 +125,000	+93%	+$16.7M	0.57%	35
2023 Q1	$20.7M	Sell	135,000 -5,000	-4%	-$825K	0.42%	40
2022 Q4	$25.1M	Sell	140,000 -14,200	-9%	-$2.32M	0.52%	34
2022 Q3	$18.2M	Sell	154,200 -25,000	-14%	-$3.79M	0.35%	44
2022 Q2	$25.6M	Buy	179,200 +3,800	+2%	+$543K	0.63%	31
2022 Q1	$30.2M	Buy	175,400 +136,400	+350%	+$23M	0.53%	35
2021 Q4	$9.9M	Buy	+39,000	New	+$11.4M	0.16%	104

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Credit Agricole's MRNA Position: Q1 2026 in Review

Credit Agricole reduced its Moderna (MRNA) stake by 7.9% in Q1 2026, selling an estimated $806K and leaving 200,797 shares worth $10.2M. The position accounts for 0.03% of the portfolio, ranked #393.

Credit Agricole first reported a position in MRNA in Q1 2020 and has held it in 23 quarters since. The position peaked at $23.1M in Q4 2023. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Credit Agricole held 200,797 shares of Moderna worth $10.2M as of Q1 2026.
Credit Agricole sold 17,266 Moderna shares in Q1 2026, an estimated $806K.
Moderna made up 0.03% of Credit Agricole's portfolio in Q1 2026, its #393 holding.
Credit Agricole first reported a position in Moderna in Q1 2020 and has held it in 23 quarters since.
Credit Agricole's Moderna position peaked at $23.1M in Q4 2023.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.